3315 related articles for article (PubMed ID: 7668266)
1. Chromosome 9p deletions in cutaneous malignant melanoma tumors: the minimal deleted region involves markers outside the p16 (CDKN2) gene.
Puig S; Ruiz A; Lázaro C; Castel T; Lynch M; Palou J; Vilalta A; Weissenbach J; Mascaro JM; Estivill X
Am J Hum Genet; 1995 Aug; 57(2):395-402. PubMed ID: 7668266
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene.
Wiest JS; Franklin WA; Otstot JT; Forbey K; Varella-Garcia M; Rao K; Drabkin H; Gemmill R; Ahrent S; Sidransky D; Saccomanno G; Fountain JW; Anderson MW
Cancer Res; 1997 Jan; 57(1):1-6. PubMed ID: 8988029
[TBL] [Abstract][Full Text] [Related]
3. Large deletions of chromosome 9p in cutaneous malignant melanoma identify patients with a high risk of developing metastases. Hospital Clinic Malignant Melanoma Group, University of Barcelona.
Puig S; Castro J; Ventura PJ; Ruiz A; Ascaso C; Malvehy J; Estivill X; Mascaro JM; Lecha M; Castel T
Melanoma Res; 2000 Jun; 10(3):231-6. PubMed ID: 10890376
[TBL] [Abstract][Full Text] [Related]
4. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
Pollock PM; Welch J; Hayward NK
Cancer Res; 2001 Feb; 61(3):1154-61. PubMed ID: 11221846
[TBL] [Abstract][Full Text] [Related]
5. Homozygous deletions within human chromosome band 9p21 in melanoma.
Fountain JW; Karayiorgou M; Ernstoff MS; Kirkwood JM; Vlock DR; Titus-Ernstoff L; Bouchard B; Vijayasaradhi S; Houghton AN; Lahti J
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10557-61. PubMed ID: 1438246
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity at chromosome 9p21 (INK4-p14ARF locus): homozygous deletions and mutations in the p16 and p14ARF genes in sporadic primary melanomas.
Kumar R; Smeds J; Lundh Rozell B; Hemminki K
Melanoma Res; 1999 Apr; 9(2):138-47. PubMed ID: 10380936
[TBL] [Abstract][Full Text] [Related]
7. Alteration of chromosome 9p21 and/or p16 in benign and dysplastic nevi suggests a role in early melanoma progression (United States).
Tran TP; Titus-Ernstoff L; Perry AE; Ernstoff MS; Newsham IF
Cancer Causes Control; 2002 Sep; 13(7):675-82. PubMed ID: 12296515
[TBL] [Abstract][Full Text] [Related]
8. Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma.
Ohta M; Berd D; Shimizu M; Nagai H; Cotticelli M-G ; Mastrangelo M; Shields JA; Shields CL; Croce CM; Huebner K
Int J Cancer; 1996 Mar; 65(6):762-7. PubMed ID: 8631588
[TBL] [Abstract][Full Text] [Related]
9. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus.
Kamb A; Shattuck-Eidens D; Eeles R; Liu Q; Gruis NA; Ding W; Hussey C; Tran T; Miki Y; Weaver-Feldhaus J
Nat Genet; 1994 Sep; 8(1):23-6. PubMed ID: 7987388
[TBL] [Abstract][Full Text] [Related]
11. Frequent allele loss on 9p21-22 defines a smallest common region in the vicinity of the CDKN2 gene in sporadic breast cancer.
An HX; Niederacher D; Picard F; van Roeyen C; Bender HG; Beckmann MW
Genes Chromosomes Cancer; 1996 Sep; 17(1):14-20. PubMed ID: 8889502
[TBL] [Abstract][Full Text] [Related]
12. Chromosome 9p deletions in invasive and noninvasive nonfunctional pituitary adenomas: the deleted region involves markers outside of the MTS1 and MTS2 genes.
Farrell WE; Simpson DJ; Bicknell JE; Talbot AJ; Bates AS; Clayton RN
Cancer Res; 1997 Jul; 57(13):2703-9. PubMed ID: 9205080
[TBL] [Abstract][Full Text] [Related]
13. Chromosome 9 deletion in sporadic and familial melanomas in vivo.
Isshiki K; Seng BA; Elder DE; Guerry D; Linnenbach AJ
Oncogene; 1994 Jun; 9(6):1649-53. PubMed ID: 8183559
[TBL] [Abstract][Full Text] [Related]
14. Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2.
Schultz DC; Vanderveer L; Buetow KH; Boente MP; Ozols RF; Hamilton TC; Godwin AK
Cancer Res; 1995 May; 55(10):2150-7. PubMed ID: 7743516
[TBL] [Abstract][Full Text] [Related]
15. Homozygous deletions but no sequence mutations in coding regions of p15 or p16 in human primary bladder tumors.
Packenham JP; Taylor JA; Anna CH; White CM; Devereux TR
Mol Carcinog; 1995 Nov; 14(3):147-51. PubMed ID: 7576106
[TBL] [Abstract][Full Text] [Related]
16. Homozygous deletions at 9p21 in childhood acute lymphoblastic leukemia detected by microsatellite analysis.
Takeuchi S; Koike M; Seriu T; Bartram CR; Slater J; Park S; Miyoshi I; Koeffler HP
Leukemia; 1997 Oct; 11(10):1636-40. PubMed ID: 9324282
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity on chromosome 1 and 9 and hormone receptor analysis of metastatic malignant melanoma presenting in breast.
Beaty MW; Quezado M; Sobel ME; Duray P; Merino MJ
Int J Surg Pathol; 2005 Jan; 13(1):9-18. PubMed ID: 15735850
[TBL] [Abstract][Full Text] [Related]
18. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR
Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033
[TBL] [Abstract][Full Text] [Related]
19. Chromosome 9p allelic loss and p16/CDKN2 in breast cancer and evidence of p16 inactivation in immortal breast epithelial cells.
Brenner AJ; Aldaz CM
Cancer Res; 1995 Jul; 55(13):2892-5. PubMed ID: 7796417
[TBL] [Abstract][Full Text] [Related]
20. High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder.
Gonzalez-Zulueta M; Shibata A; Ohneseit PF; Spruck CH; Busch C; Shamaa M; El-Baz M; Nichols PW; Gonzalgo ML; Elbaz M [corrected to El-Baz M]
J Natl Cancer Inst; 1995 Sep; 87(18):1383-93. PubMed ID: 7658499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
